Partial microglial depletion attenuates Purkinje cell degeneration and reshapes both glial and inflammatory responses in a mouse model of selective neurodegeneration
Year: 2026
Type: preprint
Abstract: Background The microglial population contributes to the inflammatory environment during neurodegeneration. Its role in neuronal loss remains hard to distinguish from its response to injury. We investigated how early pharmacological reduction of this population affects Purkinje cell preservation, behaviour and the cerebellar glial response. Methods We administered PLX5622 to Purkinje cell degeneration (PCD) and wild-type (WT) mice from postnatal day (P) 15 to P24 and compared them with their respective untreated controls. We assessed motor coordination, spontaneous behaviours and novel-object recognition at P17, P21 and P25. At P25, we quantified regional Purkinje cell preservation, glial immunoreactivity and microglial abundance and morphology. We assessed selected transcripts in whole-cerebellum samples by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results At P25, treated PCD mice showed better motor coordination, improvements in selected spontaneous behaviours and greater novel-object discrimination. Greater Purkinje cell preservation coincided with lower glial fibrillary acidic protein (GFAP) immunoreactivity in lobes IV-V and VIII. Microglial density decreased in all four PCD regions analysed. The territory encompassed by the processes of residual microglia expanded in both genotypes. In PCD mice, CD68-positive tissue area decreased in lobes I-II and IV-V, and the proportion of Iba1-positive area occupied by CD68 decreased in IV-V. CD45, CD16/32 and CD206 immunoreactivity decreased alongside selective reductions in immune, inflammatory and phagocytosis-associated transcripts. Treated WT mice showed early behavioural changes, including reduced novel-object discrimination. Conclusions Early PLX5622 treatment can modify the outcome of genetically driven cerebellar degeneration in PCD mice. The benefits achieved with partial microglial depletion provide a preclinical rationale for testing how the timing and extent of glial modulation influence neuronal protection during active degeneration.
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7235386909
